Kinisis Ventures Fund II (KVF II) announced this week that it has invested €400,000 in Smartline, the Netherlands-based company behind EQQU, a screenless smart bracelet designed as minimalist jewellery but equipped with advanced biometric sensors.

The deal brings Smartline’s total funding to €1.5 million, joining earlier backing from Hoxton Ventures and Concept Ventures in the United Kingdom.

The company is shifting from product development to go-to-market execution.

EQQU, which has drawn more than 7,000 high-intent signups, positions itself as a premium wearable that blends with mechanical watches and high-end jewellery while offering continuous monitoring of heart health, sleep, stress and daily activity.

Smartline has tested its technology in real-world conditions and is preparing for a UK launch ahead of EU and US expansion in 2026.

KVF II said the investment also strengthens its wider portfolio by enabling cross-collaborations between companies and opening pathways for founders to access international ecosystems.

It also added that “by connecting Cypriot entrepreneurs with peers from the US, Europe, and other markets, we foster knowledge exchange, collaboration, and new commercial opportunities for all.”

Andreas Panayi, founder at Kinisis Ventures and a member of the investment committees at KV Fund I and II, said “we are thrilled to back EQQU and join an exceptional syndicate of investors, including Hoxton Ventures and Concept Ventures”.

He added that the deal “perfectly aligns with our thesis around smart wearables, data-driven insights, and disruptive human-centric technologies”.

He also noted that “from Darefore’s performance sensors to IREROBOT’s haptics and Threedium’s AR platforms, we’ve consistently backed innovations that enhance the way people interact with technology, and EQQU represents a natural fit with our investment strategy by blending data, user-centric smart hardware, disruptive software, and segment-defining technology”.

EQQU Founder and CEO Dimitri Poltavtsev, a former Swarovski executive, said he was pleased to bring KV Fund II into the investor group, noting that its experience and network in the United States would be instrumental “as we move from prototypes to large-scale production and scale-up”.

The new capital will support commercial-scale production, CE/UKCA certification and the build-out of EQQU’s subscription-based health-insights platform.

Further plans include men’s editions, luxury collaborations and integrations with digital-health applications.

With the deal, KVF II continues to expand its international footprint and demonstrate its ability to syndicate alongside top-tier venture funds. Smartline plans to open pre-orders in the coming months.